These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17582908)

  • 1. Invasive Cryptococcosis and adalimumab treatment.
    Horcajada JP; Peña JL; Martínez-Taboada VM; Pina T; Belaustegui I; Cano ME; García-Palomo D; Fariñas MC
    Emerg Infect Dis; 2007 Jun; 13(6):953-5. PubMed ID: 17582908
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated histoplasmosis associated with the treatment of rheumatoid arthritis with anticytokine therapy.
    Asrani NS
    Ann Intern Med; 2008 Oct; 149(8):594-5. PubMed ID: 18936512
    [No Abstract]   [Full Text] [Related]  

  • 3. A case report of progressive multifocal leucoencephalopathy (PML) associated with adalimumab.
    Ray M; Curtis JR; Baddley JW
    Ann Rheum Dis; 2014 Jul; 73(7):1429-30. PubMed ID: 24618264
    [No Abstract]   [Full Text] [Related]  

  • 4. Kaposi's disease in a patient on adalimumab for rheumatoid arthritis.
    Bret J; Hernandez J; Aquilina C; Zabraniecki L; Fournie B
    Joint Bone Spine; 2009 Dec; 76(6):721-2. PubMed ID: 19945327
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
    Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
    Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
    [No Abstract]   [Full Text] [Related]  

  • 6. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab.
    Bassetti M; Pizzorni C; Gradoni L; Del Bono V; Cutolo M; Viscoli C
    Rheumatology (Oxford); 2006 Nov; 45(11):1446-8. PubMed ID: 16887847
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium chelonae infection associated with adalimumab therapy.
    Díaz F; Urkijo JC; Mendoza F; de la Viuda JM; Blanco M; Unzurrunzaga A; Ayarza R
    Scand J Rheumatol; 2008; 37(2):159-60. PubMed ID: 18415777
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculous peritonitis after treatment with adalimumab.
    Antolín J; Azahara M; Hernández C; Blanco M; Mao L; Cigüenza R
    Scand J Infect Dis; 2008; 40(8):677-8. PubMed ID: 18979608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell arteritis during adalimumab treatment for rheumatoid arthritis.
    Leydet-Quilici H; Luc M; Armingeat T; Pham T; Lafforgue P
    Joint Bone Spine; 2007 May; 74(3):303-4. PubMed ID: 17379563
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab-associated pulmonary cryptococcosis.
    Iwata T; Nagano T; Tomita M; Suehiro Y; Nakatsuka S; Kimura H; Sakaki M
    Ann Thorac Cardiovasc Surg; 2011; 17(4):390-3. PubMed ID: 21881327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab.
    Schoe A; van der Laan-Baalbergen NE; Huizinga TW; Breedveld FC; van Laar JM
    Arthritis Rheum; 2006 Feb; 55(1):157-9. PubMed ID: 16463430
    [No Abstract]   [Full Text] [Related]  

  • 12. Unusual flexural drug reaction with epidermal pustules associated with adalimumab treatment.
    Kristjansson AK; Poulos GA; Chang T; Gilliam AC; Cooper KD
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S108-9. PubMed ID: 18489037
    [No Abstract]   [Full Text] [Related]  

  • 13. Adalimumab-induced neutropenia in a patient with rheumatoid arthritis.
    Ottaviani S; Cerf-Payrastre I; Kemiche F; Pertuiset E
    Joint Bone Spine; 2009 May; 76(3):312-3. PubMed ID: 19289296
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary cutaneous cryptococcosis during infliximab therapy.
    Chiriac A; Mares M; Mihaila D; Solovan C; Moldovan C; Stolnicu S; Hagen F
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27637071
    [No Abstract]   [Full Text] [Related]  

  • 15. Visceral Leishmaniasis among immunosuppressed patients with rheumatic diseases.
    Erre GL; Mesina P; Tonelli N; Passiu G
    Clin Exp Rheumatol; 2010; 28(4):590-1. PubMed ID: 20659417
    [No Abstract]   [Full Text] [Related]  

  • 16. Aseptic meningitis possibly induced by adalimumab.
    Jazeron A; Lallier JC; Rihn B; Thiercelin MC
    Joint Bone Spine; 2010 Dec; 77(6):618-9. PubMed ID: 20656540
    [No Abstract]   [Full Text] [Related]  

  • 17. Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis.
    Scrivo R; Spadaro A; Iagnocco A; Valesini G
    Clin Exp Rheumatol; 2007; 25(1):117. PubMed ID: 17418005
    [No Abstract]   [Full Text] [Related]  

  • 18. Disseminated Cryptococcus neoformans after treatment with infliximab for rheumatoid arthritis.
    Kozic H; Riggs K; Ringpfeil F; Lee JB
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S95-6. PubMed ID: 18489059
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Hochman D; Wolff B
    JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Callegari PE; Schaible TF; Boscia JA
    JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.